HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CAY 10580

a E-prostanoid EP4 receptor agonist

Also Known As:

CAY-10580; CAY10580

Networked: 2 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Cai, Yin: 1 article (01/2018)
2.	Chen, Xin Yi: 1 article (01/2018)
3.	Huang, Ianto Bosheng: 1 article (01/2018)
4.	Tang, Eva Hoi Ching: 1 article (01/2018)
5.	Vanhoutte, Paul M: 1 article (01/2018)
6.	Wong, Hoi Kin: 1 article (01/2018)
7.	Xia, Zhengyuan: 1 article (01/2018)
8.	Xu, Aimin: 1 article (01/2018)
9.	Ying, Fan: 1 article (01/2018)
10.	Kappes, John C: 1 article (01/2015)

Related Diseases

1.	Melanoma (Melanoma, Malignant) 01/01/2015 - "GSPs treatment inhibit butaprost (EP2 agonist) or Cay10580 (EP4 agonist) induced migration of melanoma cells. "
2.	Hypercholesterolemia 01/01/2018 - "Treating high fat diet-challenged mice with the pharmacological EP4 agonist, CAY10580 (200 μg/kg body weight/day i.p) for three weeks effectively prevented diet-induced hypercholesterolemia, enhanced endogenous bile acid synthesis and their fecal excretion. "
3.	Body Weight (Weight, Body) 01/01/2018 - "Treating high fat diet-challenged mice with the pharmacological EP4 agonist, CAY10580 (200 μg/kg body weight/day i.p) for three weeks effectively prevented diet-induced hypercholesterolemia, enhanced endogenous bile acid synthesis and their fecal excretion. "

Related Drugs and Biologics

1.	Bile Acids and Salts (Bile Acids)
2.	butaprost